The application of proteomics to fetal and maternal medicine

Fetal and Maternal Medicine Review

Volumn 14, Issue 1, 2003, Pages 47-55

  De Wit, N C J ^a,b   Vatish, M ^a   Heck, A J R ^b   Thornton, S ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOINFORMATICS; GENOMICS; MASS SPECTROMETRY; PROTEIN DEGRADATION; PROTEOMICS; REVIEW; STAINING; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0037837452     PISSN: 09655395     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0965539503001025     Document Type: Review

References (17)

1. Lockhart D, Winzeler E. Genomics, gene expression and DNA arrays. Nature 2000; 405: 827-36.
2. Lipshutz RJ, Fodor SP, Gingeras TR, Lockhart DJ. High density synthetic oligonucleotide arrays. Nat Genet 1999; 21: 20-24. (supplement)
3. Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature 1999; 402: 715-20.
4. Gygi S, Rochon Y, Franza B, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999; 19: 1720-730.
5. Larsen M, Roepstorff P. Mass spectrometric identification of proteins and characterization of their post-translational modifications in proteome analysis. Fresenius J Anal Chem 2000; 366: 677-90.
6. Jennings K. Mass Spectrometry, past, present and future. CAST 2000; January/February: 18-22.
7. Wassinger VC, Cordwell SJ, Cerpa-Poljak A, Yan JX, Gooley AA, Wilkins MR et al. Progress with geneproduct mapping of the mollicutes: Mycoplasma genitalium. Electrophoresis 1995; 16: 1090-1094.
8. Wilm M, Mann M. Analytical properties of the nanoelectrospray ion source. Anal Chem 1996; 68: 1-8.
9. Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem 1994; 66: 4390-399.
10. Rabilloud T, Kieffer S, Procaccio V, Louwagie M, Courchesne PL, Patterson SD et al. Two-dimensional electrophoresis of human placental mitochondria and protein identification by mass spectrometry: Toward a human mitochondrial proteome. Electrophoresis 1998; 19: 1006-1014.
11. Hoang VM, Foulk R, Clauser K, Burlingame A, Gibson BW, Fisher SJ. Functional proteomics: Examining the effects of hypoxia on the cytotrophoblast protein repertoire. Biochemistry 2001; 40: 4077-4086.
12. Cheon MS, Fountoulakis M, Dierssen M, Ferreres JC, Lubec G. Expression profiles of proteins with Down syndrome. J Neural Transm Suppl 2001; 61: 311-19.
13. Opperman M, Cols N, Nyman T, Helin J, Saarinen J, Byman I et al. Identification of foetal brain proteins by two-dimensional gel electrophoresis and mass spectrometry. Comparison of samples from individuals with or without chromosome 21 trisomy. Eur J Biochem 2000; 267: 4713-719.
14. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet 1999; 354: 810-16.
15. Mitchell P. A perspective on protein microarrays. Nat Biotechnol 2002; 20: 225-29.
16. Hancock WS, Wu SL, Shieh P. The challenges of developing a sound proteomics strategy. Proteomics 2002, 2: 352-59.
17. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359: 572-77.